Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Kandel

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Trials|July 9, 2026
Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trialConnor Prosty, Alex Carignan, Adrienne K Chan, et al.
Canadian Journal of Kidney Health and Disease|March 23, 2023
Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research ProtocolKevin Yau, Omosomi Enilama, Adeera Levin, et al.
BMJ Open|December 8, 2025
Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCENick Daneman, Jennie Johnstone, Todd C Lee, et al.
JAMA Internal Medicine|July 6, 2026
Respiratory Outbreak Mitigation With Point-of-Care Testing in Long-Term Care: A Randomized Clinical TrialChristopher Kandel, Daphne Oriotis, Heather L Candon, et al.
Vaccine|March 5, 2026
Prevalence of and risk factors for antimicrobial resistance in pneumococcal disease in southern Ontario during the PCV13 eraAltynay Shigayeva, Brenda L Coleman, Alyssa R Golden, et al.
JAMA Network Open|February 10, 2026
Invasive Group A Streptococcal Disease in Persons Experiencing Postpandemic Homelessness in CanadaCaroline Kassee, Halima Dabaja-Younis, Lucie Richard, et al.
Eclinicalmedicine|April 21, 2025
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trialSean W X Ong, Ruxandra Pinto, Asgar Rishu, et al.
The Lancet. Respiratory Medicine|February 8, 2021
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trialJordan J Feld, Christopher Kandel, Mia J Biondi, et al.
JAMA Network Open|April 1, 2025
Invasive Group A Streptococcal Infection in Children, 1992-2023Halima Dabaja-Younis, Christopher Kandel, Karen Green, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 6, 2026
Incidence of colonization and infection with carbapenemase-producing Enterobacterales in Toronto and Peel Region, Ontario, 2007-2024Angel Xinliu Li, Maxime Lefebvre, Zoe Zhong, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Trials|July 9, 2026
Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trialConnor Prosty, Alex Carignan, Adrienne K Chan, et al.
Canadian Journal of Kidney Health and Disease|March 23, 2023
Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research ProtocolKevin Yau, Omosomi Enilama, Adeera Levin, et al.
BMJ Open|December 8, 2025
Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCENick Daneman, Jennie Johnstone, Todd C Lee, et al.
JAMA Internal Medicine|July 6, 2026
Respiratory Outbreak Mitigation With Point-of-Care Testing in Long-Term Care: A Randomized Clinical TrialChristopher Kandel, Daphne Oriotis, Heather L Candon, et al.
Vaccine|March 5, 2026
Prevalence of and risk factors for antimicrobial resistance in pneumococcal disease in southern Ontario during the PCV13 eraAltynay Shigayeva, Brenda L Coleman, Alyssa R Golden, et al.
JAMA Network Open|February 10, 2026
Invasive Group A Streptococcal Disease in Persons Experiencing Postpandemic Homelessness in CanadaCaroline Kassee, Halima Dabaja-Younis, Lucie Richard, et al.
Eclinicalmedicine|April 21, 2025
Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection: an exploratory post-hoc analysis of the BALANCE randomised clinical trialSean W X Ong, Ruxandra Pinto, Asgar Rishu, et al.
The Lancet. Respiratory Medicine|February 8, 2021
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trialJordan J Feld, Christopher Kandel, Mia J Biondi, et al.
JAMA Network Open|April 1, 2025
Invasive Group A Streptococcal Infection in Children, 1992-2023Halima Dabaja-Younis, Christopher Kandel, Karen Green, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 6, 2026
Incidence of colonization and infection with carbapenemase-producing Enterobacterales in Toronto and Peel Region, Ontario, 2007-2024Angel Xinliu Li, Maxime Lefebvre, Zoe Zhong, et al.
Pageof 5